Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
暂无分享,去创建一个
[1] M. Bardella,et al. Gastric emptying and plasma neurotensin levels in untreated celiac patients. , 2000, Scandinavian journal of gastroenterology.
[2] U. Fuhr,et al. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). , 1989, The American journal of medicine.
[3] Raymond C Rowe,et al. Handbook of Pharmaceutical Excipients , 1994 .
[4] H. Fukui,et al. Evaluation of a floating dosage form of nicardipine hydrochloride and hydroxypropylmethylcellulose acetate succinate prepared using a twin-screw extruder. , 2001, International journal of pharmaceutics.
[5] Y. Kawashima,et al. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] Kalakonda Sri Nataraj,et al. The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets. , 2002, Biological & pharmaceutical bulletin.
[7] Y. Kawashima,et al. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo) , 1991 .
[8] H. Przuntek,et al. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test , 2005, Neuroscience Letters.
[9] R. Nagashama. MECHANISM OF ACTION OF SUCRALFATE , 1981 .
[10] D. L. Munday. Film Coated Pellets Containing Verapamil Hydrochloride: Enhanced Dissolution into Neutral Medium , 2003, Drug development and industrial pharmacy.
[11] C. T. Rhodes,et al. Optimization of Sotalol Floating and Bioadhesive Extended Release Tablet Formulations , 1995 .
[12] Zhenping Wei,et al. Design and Evaluation of a Two-Layer Floating Tablet for Gastric Retention Using Cisapride as a Model Drug , 2001, Drug development and industrial pharmacy.
[13] Y. Fujibayashi,et al. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[14] Y. Kawashima,et al. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. , 1992, Journal of pharmaceutical sciences.
[15] Matteo Cerea,et al. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. , 2004, International journal of pharmaceutics.
[16] J. Mcginity,et al. Influence of Thermal Processing on the Properties of Chlorpheniramine Maleate Tablets Containing an Acrylic Polymer , 2002, Pharmaceutical development and technology.
[17] K. Ofori-Kwakye,et al. Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release. , 2004, International journal of pharmaceutics.
[18] J. Dressman,et al. Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women , 1993, Pharmaceutical Research.
[19] J. Mcginity,et al. Properties of theophylline tablets powder-coated with methacrylate ester copolymers , 2004 .
[20] Hirofumi Takeuchi,et al. In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[21] Y. Kawashima,et al. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. , 2004, International journal of pharmaceutics.
[22] Khouloud A. Alkhamis,et al. Prediction of the adsorption of diazepam by activated carbon in aqueous media. , 2003, Journal of pharmaceutical sciences.
[23] J. Konturek,et al. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. , 2001, Scandinavian journal of gastroenterology.
[24] H. Mobley,et al. Characterization of urease from Campylobacter pylori , 1988, Journal of clinical microbiology.
[25] R. F. Bauer. Misoprostol preclinical pharmacology , 1985, Digestive Diseases and Sciences.
[26] J. Mcginity,et al. Properties of Tablets Containing Granulations of Ibuprofen and an Acrylic Copolymer Prepared by Thermal Processes , 2001, Pharmaceutical development and technology.
[27] J. Siepmann,et al. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] R. Nagashima. Mechanisms of action of sucralfate. , 1981, Journal of clinical gastroenterology.
[29] Y. Seta,et al. Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties , 1988 .
[30] S. Ramalingam,et al. A Kinetic Study of the Solid State Transformation of Sodium Bicarbonate to Sodium Carbonate , 1974 .